Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

Friday’s trading has closed, but VNDA is being traded in the after-hours session. After-Hours quote »
12.11
Delayed Data
As of 3:59pm ET
 +0.18 / +1.51%
Today’s Change
8.34
Today|||52-Week Range
15.51
-15.43%
Year-to-Date

Today’s Trading

Previous close11.93
Today’s open11.88
Day’s range11.80 - 12.24
Volume560,343
Average volume (3 months)795,287
Market cap$504.5M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+83.33%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+48.05%
P/E ratio9.4
Price/Sales10.47
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...-0.21-1.48%
CARACara Therapeutics In...+0.08+0.42%
OTICOtonomy Inc+0.54+2.50%
SRNESorrento Therapeutic...+0.17+1.34%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$50.2M
Annual profit (last year)$20.2M
Net profit margin40.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
CFO, Secretary, Treasurer &
Senior Vice President
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts

Partner Offers